Categories
Tags
Abbott Advertising AstraZeneca Barack Obama Big Pharma Biotechnology and Pharmaceuticals Bristol Myers Squibb business Cancer Clinical trial conference Deal Eli Lilly European Commission European Union Facebook FDA Food and Drug Administration Genentech generics GlaxoSmithKline Google GSK HBA Health Health care Johnson & Johnson layoffs Lilly Marketing Merck Novartis Pfizer Pharma Pharmaceutical drug pharmaceutical industry Research and development Roche Sanofi-Aventis Schering Plough social media Twitter U.S. Food and Drug Administration United States Wyeth
Technology News
BioPharm News

Sanofi Executive Change Up
Barely a week after former Glaxo executive Chris Viehbacher assumed the role of CEO, Sanofi-Aventis announced that Jean-Claude Leroy, the company’s executive vp of finance and legal, has left the company. In a short statement, the company noted that his position will be filled by two people, reporting directly to Viehbacher; they are CFO Laurence Debroux, and Karen Linehan, general counsel. So far, no one has commented as to the reason for Leroy’s departure.